MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Development of a tool for assessment of embarrassment due to dystonia

    R. Verma, K.S. Anand (New Delhi, India)

    Objective: To develop a self assessment scale for quantitative measurement of embarrassment in patients having dystonia. Background: Patients suffering from movement abnormalities like dystonia frequently…
  • 2016 International Congress

    Reliability of a newly developed protocol for fiberoptic endoscopic evaluation of swallowing in Parkinson’s patients (PARK-FEES)

    J.A. Simons, S. von Clarmann, T. Warnecke (Lübeck, Germany)

    Objective: A new FEES protocol specified for dysphagia diagnosis among Parkinson's disease (PD) patients was recently developed in a prior two-phased study¹, which is now…
  • 2016 International Congress

    Comparison of change in the UPDRS verses MDS-UPDRS in a population of Parkinson’s disease (PD) patients treated with deep brain stimulation (DBS)

    S.S. Wang, N.B. Galifianakis, M. San Luciano, P.S. Larson, P.A. Starr, N. Ziman, J.L. Ostrem (San Francisco, CA, USA)

    Objective: To compare assessment tools for capturing the therapeutic effect of DBS for treating PD using the original UPDRS and The Movement Disorder Society-sponsored revision…
  • 2016 International Congress

    The dopamine agonist withdrawal syndrome rating scale (DAWS-RS): Initial development of a new non-motor scale

    L.S. Croll, K.M. Montgomery, C.V. Kulick, M.J. Nirenberg (New York, NY, USA)

    Objective: To describe the development of the dopamine agonist withdrawal syndrome (DAWS) rating scale (DAWS-RS), a new questionnaire designed to evaluate the symptoms, severity, and…
  • 2016 International Congress

    Diaphragmatic dystonia in a patient that presents with Meige syndrome and disordered breathing

    N. Licking, B. Farro (Portland, OR, USA)

    Objective: To present a case of diaphragmatic dystonia, discuss prevalence, and a practical approach to work up and treatment of this condition. Background: Diaphragmatic dystonia…
  • 2016 International Congress

    Brain networks revealed by resting state functional MRI in familial and sporadic primary dystonia

    K. Fujita, A. Vo, D. Eidelberg (Manhasset, NY, USA)

    Objective: To identify disease-related brain networks in hereditary and sporadic primary dystonia using resting state fMRI (rs-fMRI). Background: Abnormalities of the cerebello-thalamo-cortical (CbTC) pathways have…
  • 2016 International Congress

    Striatal and pedunculopontine nucleus diffusion tensor imaging in cervical dystonia

    K. Mente, A. Holmes, D. Urbano, M. Hallett, S.G. Horovitz (Bethesda, MD, USA)

    Objective: To characterize white matter integrity in the striatum and pedunculopontine nucleus (PPN) in patients with cervical dystonia using diffusion tensor imaging (DTI). Background: The…
  • 2016 International Congress

    Impaired processing of visuo-spatial information in cervical dystonia patients

    C.J. Amlang, C. Hubsch-Bonneaud, S. Rivaud-Pechoux, S. Mehdi, A. El Helou, Y. Trotter, J.B. Durand, P. Pouget, M. Vidailhet (Berlin, Germany)

    Objective: The goal of our study was to investigate the spatial distribution of visual processing resources in cervical dystonia (CD) patients with a pure left…
  • 2016 International Congress

    Yearly four months’ disability gap in cervical dystonia due to run-out botulinum toxin effect

    K.K. Martikainen, S. Kinos, R.J. Marttila (Turku, Finland)

    Objective: To investigate the causes of disability in patients with cervical dystonia. Background: Despite the development of medical treatment, cervical dystonia impairs the daily living…
  • 2016 International Congress

    An update on genotype-phenotype correlation in X-linked dystonia-parkinsonism (XDP/DYT3)

    M.E. Dy, C.M. De Gusmao, M.E. Talkowski, T.J. Multhaupt-Buell, L.R. Paul, C. Bragg, N. Sharma (Boston, MA, USA)

    Objective: To further characterize the severity, movement abnormalities, and disease course in an expanded cohort of subjects and their families with XDP and determine if…
  • « Previous Page
  • 1
  • …
  • 1679
  • 1680
  • 1681
  • 1682
  • 1683
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley